|
|
Volumn 9, Issue 5, 2015, Pages 358-367
|
|
American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
BUPRENORPHINE;
CANNABIS;
CLONIDINE;
FENTANYL;
HEPATITIS A VACCINE;
HEPATITIS B VACCINE;
HYPNOTIC SEDATIVE AGENT;
KETOROLAC;
LOPERAMIDE;
METHADONE;
NALOXONE;
NALTREXONE;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
ONDANSETRON;
OPIATE;
PARACETAMOL;
NARCOTIC ANALGESIC AGENT;
NARCOTIC ANTAGONIST;
ABSENCE OF SIDE EFFECTS;
AGE DISTRIBUTION;
ALCOHOL CONSUMPTION;
ANESTHESIA;
ANXIETY DISORDER;
BREAST FEEDING;
CANNABIS ADDICTION;
CESAREAN SECTION;
CHILD CARE;
CLINICAL COMPETENCE;
CLINICAL DECISION MAKING;
COMORBIDITY;
CONSCIOUS SEDATION;
CONTROLLED RELEASE FORMULATION;
DEATH;
DIARRHEA;
DISEASE SEVERITY;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG CHOICE;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG DEPENDENCE;
DRUG DETOXIFICATION;
DRUG DOSE COMPARISON;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG MEGADOSE;
DRUG MONITORING;
DRUG OVERDOSE;
DRUG POTENCY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SCREENING;
DRUG SUBSTITUTION;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
DRUG TOLERANCE;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
DSM-5;
ENVIRONMENTAL FACTOR;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
GROUP THERAPY;
GYNECOLOGIST;
HEALTH CARE DELIVERY;
HEALTH CARE FACILITY;
HEALTH CARE PERSONNEL;
HEALTH PROGRAM;
HEPATITIS A;
HEPATITIS B;
HEPATITIS C;
HOMELESSNESS;
HOMICIDE;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOTENSION;
INFECTION PREVENTION;
INFORMED CONSENT;
LABORATORY TEST;
LAW;
LIVER FUNCTION TEST;
LOW DRUG DOSE;
MEDICAL HISTORY;
MEDICAL PROCEDURES;
MEDICAL RECORD;
MEDICAL SOCIETY;
MENTAL DISEASE;
NAUSEA;
OBSTETRICIAN;
OFF LABEL DRUG USE;
OFFICE-BASED OPIOID TREATMENT;
OPIATE ADDICTION;
PAIN;
PATIENT CARE;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PATIENT REFERRAL;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PREGNANT WOMAN;
PRENATAL CARE;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PRISONER;
PROPHYLAXIS;
PROVOCATION TEST;
PSYCHOSOCIAL CARE;
PUNISHMENT;
RATING SCALE;
RECOMMENDED DRUG DOSE;
RELAPSE;
RESPIRATION DEPRESSION;
REVIEW;
RISK REDUCTION;
SCHIZOPHRENIA;
SERODIAGNOSIS;
SEXUALLY TRANSMITTED DISEASE;
SINGLE DRUG DOSE;
SMOKING CESSATION;
SOCIAL ASPECT;
STANDARDIZATION;
SUICIDAL IDEATION;
TOBACCO USE;
TREATMENT PLANNING;
ULTRARAPID OPIOID DETOXIFICATION;
UNSPECIFIED SIDE EFFECT;
URINALYSIS;
VACCINATION;
WITHDRAWAL SYNDROME;
MULTIMODALITY CANCER THERAPY;
OPIOID-RELATED DISORDERS;
PSYCHOTHERAPY;
VULNERABLE POPULATION;
ANALGESICS, OPIOID;
BUPRENORPHINE;
COMBINED MODALITY THERAPY;
DRUG OVERDOSE;
HUMANS;
METHADONE;
NALOXONE;
NALTREXONE;
NARCOTIC ANTAGONISTS;
OPIOID-RELATED DISORDERS;
PSYCHOTHERAPY;
VULNERABLE POPULATIONS;
|
|
EID: 84957045621
PISSN: 19320620
EISSN: 19353227
Source Type: Journal
DOI: 10.1097/ADM.0000000000000166 Document Type: Review |
|
Times cited : (448)
|
|
References (0)
|
